TITLE

COMMENTARY: Olanzapine, quetiapine, or risperidone did not differ from placebo for Alzheimer disease

AUTHOR(S)
Larsan, Eric; McCurry, Susan
PUB. DATE
March 2007
SOURCE
ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p35
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article presents the authors' comment on a research study that compares the effect of antipsychotic drugs and placebo in the patients of Alzheimer disease, psychosis and aggression. The author praises the study and says that it adds to the evidence base in pharmacotherapeutics. The author mentions that 82 percent of patients discontinue medication due to their adverse effects that lead to parkinsonism and sedation.
ACCESSION #
24685664

 

Related Articles

  • Olanzapine, quetiapine, or risperidone did not differ from placebo for Alzheimer disease.  // ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p35 

    The article cites a research study that compares the effect of antipsychotic drugs and placebo in the patients of Alzheimer disease (AD), psychosis and aggression. A randomized controlled trial was conducted of 421 outpatients, who had AD or probable AD. The researchers came to the conclusion...

  • Review: higher rates of attrition in antipsychotic treatment arms of placebo controlled trials than in trials with active comparators. Stroup, T. Scott // Evidence Based Mental Health;Aug2006, Vol. 9 Issue 3, p70 

    The article comments on the study by G. Kemmler and colleagues on the rates of attrition in antipsychotic treatment arms of placebo controlled trials that in those of active comparator trials. The authors of the study confirm that dropout rates in placebo controlled trials of antipsychotic drugs...

  • Aripiprazole in acute mania associated with bipolar I disorder: profile report. Adis International Limited // Drugs & Therapy Perspectives;Dec2004, Vol. 20 Issue 12, p5 

    Reports on the results of clinical trials for Aripiprazole, an atypical antipsychotic drug, in the treatment of bipolar I disorder with acute manic or mixed episode. Features and properties of the drug; Result of a comparative trial with a placebo; Assessment of the tolerability of the drug;...

  • Treating behavioral and psychological signs in Alzheimer's disease. Ballard, Clive; O'Brien, John // BMJ: British Medical Journal (International Edition);07/17/99, Vol. 319 Issue 7203, p138 

    Editorial. Focuses on the management of behavioral and psychological signs of dementia or Alzheimer's disease. Side effects of neuroleptic drugs used for treating dementia; How clinical trials group together different behavioral and psychological signs; How intervention trials for signs of...

  • Antipsychotic use and risk of hospitalisation or death due to pneumonia in persons with and without Alzheimer's disease.  // NAPPP Monthly Newsletter;Oct2016, Vol. 11 Issue 10, p9 

    The article presents a study which examined whether the use of antipsychotic drugs or specific antipsychotics are linked to higher risk of hospitalization or death due to pneumonia in persons with or without Alzheimer's disease (AD). The subjects of the study are patients with AD in Finland in...

  • Aripiprazole.  // Reactions Weekly;4/25/2009, Issue 1249, p7 

    The article describes the case of a 26-year-old man with schizophrenia who developed supersensitivity psychosis after receiving aripiprazole. Although stable on olanzapine, he decided to switched gradually to aripiprazole because of weight gain. After months of taking aripiprazole, he started to...

  • Olanzapine.  // Reactions Weekly;11/1/2008, Issue 1226, p21 

    The article describes the case of a 36-year-old man with psychosis who developed pancytopenia after receiving olanzapine. Eight says of administering olanzapine, he developed pancytopenia. Days after discontinuing olanzapine, his white blood cell (WBC) and platelet counts started to normalize....

  • Delusions of Parasitosis: A Dermatologist's Guide to Diagnosis and Treatment. Koo, John; Lee, Chai Sue // American Journal of Clinical Dermatology;Sep/Oct2001, Vol. 2 Issue 5, p285 

    Delusions of parasitosis is a rare psychiatric disorder in which the patient has a fixed, false belief that he or she is infested by parasites. Even though it is a psychiatric disorder, these patients usually present to a dermatologist because they are convinced that they have a dermatological...

  • Aripiprazole.  // Reactions Weekly;2/12/2011, Issue 1338, p8 

    The article describes the case of a 39-year-old schizophrenic man who experienced worsening psychosis following treatment with aripiprazole.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics